Our results confirm the hypothesis that CYP1A1Ile462Val, in association with a long period of active smoking, could be a possible breast cancer risk factor and also support the main effect of CYP1A1 in estrogenic metabolism rather than in tobacco carcinogen activation in breast cancer patients. Here, CYP1A1 is linked to breast cancer.